CBD /

 

Search

Custom query TAKE SEARCH TOUR
Search Clear
  • Sort
  • Export


Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Commercial Release of the Vectormune FP-LT-AE Vaccine - Technical Opinion No. 2958/2011.
  • Country's Decision or any other Communication
  • bch-dec-br-299618-1
  • 25 Jun 2026
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Risk assessment of the Vectormune FP-LT-AE Vaccine - Technical Opinion No. 2958/2011.
  • Risk Assessment generated by a regulatory process
  • bch-ra-br-299526-1
  • 16 Jun 2026
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
VECTORMUNE® FP-LT Vaccine
  • Living Modified Organism
  • bch-lmo-scbd-105206-1
  • 22 Jan 2014
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Commercial release of a biological product for veterinary use, namely VECTORMUNE® FP-LT+AE- Fowl Pox and avian Laryngotracheitis vaccine and avian encephalomyelitis
  • Country's Decision or any other Communication
  • bch-dec-br-105215-1
  • 09 Jan 2014
Loading...
()
  |  
  |   PDF   |   Print   |  
|  Close
Risk Assessment of a biological product for veterinary use, namely VECTORMUNE® FP-LT+AE- Fowl Pox and avian Laryngotracheitis vaccine and avian encephalomyelitis
  • Risk Assessment generated by a regulatory process
  • bch-ra-br-105214-1
  • 09 Jan 2014
Please wait for the query to finish before exporting.

Quick links

About the BCH About the Cartagena Protocol Supplementary Protocol

Sign in Search records Submit records
Registries: LMO-Organism-Gene Country Profiles
National Report Analyzer

Forums BCH Announcements

Need help?

Knowledge Base FAQs UNEP eLearning Training Site

Contact us at: bch@cbd.int
BCH Biosafety Clearing-House
Subscribe to e-mail notifications
Subscribe to our newsletter